Regulus Stock Surges on Positive Phase I HCV Data; Phase II on Deck for 2015

 

New Data Suggest Atypical microRNA Can Pass through the Gut, Stir Controversy

 

Two Studies Uncover New Non-RNAi Roles for Argonaute-1, Dicer

 

Alnylam Launches Screening Assistance Program for Genetic Diseases

 

Tekmira Begins Manufacture of Ebola Drug for Variant Involved in Outbreak

 

IP Update: Recent Patents Awarded to Devgen, Alnylam, Alcon, and More

 

Transgenomic Raises $2.4M in Private Placement

 

Researchers Sequence High-Quality Genome for 45,000-Year-Old Modern Human

 

Enigma Dx Inks Joint Venture, $50M Subscription Agreements

 

MDx Platform Firm InSilixa Completes $13M Financing Round